ChemicalBook--->CAS DataBase List--->153049-48-0

153049-48-0

153049-48-0 Structure

153049-48-0 Structure
IdentificationBack Directory
[Name]

Quinoline, 1,2,3,4-tetrahydro-1-methyl-8-(2-morpholinylmethoxy)-, methanesulfonate (1:1)
[CAS]

153049-48-0
[Synonyms]

S12024-2
S 12024-2
S-12024-2
UNII-03045W04DP
S 120242,S 12024 2
Dabelotine mesilate
Quinoline, 1,2,3,4-tetrahydro-1-methyl-8-(2-morpholinylmethoxy)-, methanesulfonate (1:1)
[Molecular Formula]

C16H26N2O5S
[MOL File]

153049-48-0.mol
[Molecular Weight]

358.45
Hazard InformationBack Directory
[Uses]

Dabelotine (methanesulfonate) is a cognitive enhancer. Dabelotine (methanesulfonate) can be used for Alzheimer disease (AD) research[1].
[References]

[1] Gualtieri F, et al. Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs[J]. Current pharmaceutical design, 2002, 8(2): 125-138. DOI:10.2174/1381612023396582
[2] Huan WANG, et al. Method of making 1-(acyloxy)-alkyl carbamate compounds.US20140243544A1.2016-06-21
153049-48-0 suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354; +17819995354 , +17819995354
Website: https://www.targetmol.com/
Company Name: TargetMol Chemicals Inc.
Tel: +17819995354 , +17819995354
Website:
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Website: https://www.targetmol.cn/
Tags:153049-48-0 Related Product Information

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.